Moneycontrol PRO
Check Credit Score
Check Credit Score
HomeNewsBusinessIPO

Balaji Amines arm files draft papers with Sebi for IPO

The offer consists of a fresh issue of equity shares worth Rs 250 crore and an offer for sale of 2.6 crore shares by certain existing and eligible shareholders of Balaji Speciality Chemicals.

August 12, 2022 / 07:30 AM IST
(Representative Image)

(Representative Image)

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Balaji Amines' subsidiary Balaji Speciality Chemicals has filed a draft red herring prospectus with capital markets regulator SEBI for fund raising via an initial public offering.

The offer consists of a fresh issue of equity shares worth Rs 250 crore and an offer for sale of 2.6 crore shares by certain existing and eligible shareholders of Balaji Speciality Chemicals.

Balaji Amines will not be participating in the proposed offer.

The company said it has filed draft papers on August 10.

Also Read - Syrma SGS Technology to launch IPO on August 12, fresh issue size at Rs 766 crore

In June, the board of directors of Balaji Speciality Chemicals gave approval for fund raising through initial public offer of equity shares.

Click Here To Read All IPO Related News

Balaji Speciality Chemicals manufactures niche chemicals such as ethylene diamine (EDA), piperazine anhydrous (PIP), diethylenetriamine (DETA), aminoethyl ethanolamine (AEEA) and aminoethyl piperazine (AEP), using the monoethanol amine (MEA) process. These chemicals are used in various end-use industries such as speciality chemicals, agrochemicals, and pharmaceuticals.

Sunil Shankar Matkar
first published: Aug 11, 2022 08:23 pm

Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347